A-alpha-C (2-Amino-9H-pyrido[2,3- b]indole) |
cancer |
AB |
26148-68-5 |
1-Jan-90 |
2 |
Acetaldehyde |
cancer |
SQE |
75-07-0 |
1-Apr-88 |
90
(inhalation) |
Acetamide |
cancer |
AB |
60-35-5 |
1-Jan-90 |
10 |
Acetazolamide |
developmental |
FR |
59-66-5 |
20-Aug-99 |
|
Acetochlor |
cancer |
SQE |
34256-82-1 |
1-Jan-89 |
|
Acetohydroxamic acid |
developmental |
FR |
546-88-3 |
1-Apr-90 |
|
2-Acetylaminofluorene |
cancer |
SQE |
53-96-3 |
1-Jul-87 |
0.2 |
Acifluorfen sodium |
cancer |
AB |
62476-59-9 |
1-Jan-90 |
|
Acrylamide |
cancer |
AB |
79-06-1 |
1-Jan-90 |
0.2 |
Acrylamide |
developmental, male |
AB |
79-06-1 |
25-Feb-11 |
140 |
Acrylonitrile |
cancer |
FR |
107-13-1 |
1-Jul-87 |
0.7 |
Actinomycin D [Basis for listing changed effective February 22, 2013] |
cancer |
FR |
50-76-0 |
1-Oct-89 |
0.00008 |
Actinomycin D |
developmental |
FR |
50-76-0 |
1-Oct-92 |
|
AF-2;[2-(2-furyl)-3-(5-nitro-2- furyl)]acrylamide |
cancer |
SQE |
3688-53-7 |
1-Jul-87 |
3 |
Aflatoxins |
cancer |
SQE |
--- |
1-Jan-88 |
|
Alachlor |
cancer |
SQE |
15972-60-8 |
1-Jan-89 |
|
Alcoholic beverages, when associated with alcohol abuse |
cancer |
SQE |
--- |
1-Jul-88 |
|
Aldrin |
cancer |
SQE |
309-00-2 |
1-Jul-88 |
0.04 |
All-trans retinoic acid |
developmental |
SQE |
302-79-4 |
1-Jan-89 |
|
Allyl chloride [Delisted October 29, 1999] |
|
|
|
|
|
Alprazolam |
developmental |
FR |
28981-97-7 |
1-Jul-90 |
|
Altretamine |
developmental, male |
FR |
645-05-6 |
20-Aug-99 |
|
Amantadine hydrochloride |
developmental |
FR |
665-66-7 |
27-Feb-01 |
|
Amikacin sulfate |
developmental |
FR |
39831-55-5 |
1-Jul-90 |
|
2-Aminoanthraquinone |
cancer |
LC |
117-79-3 |
1-Oct-89 |
20 |
p-Aminoazobenzene |
cancer |
AB |
60-09-3 |
1-Jan-90 |
|
o-Aminoazotoluene |
cancer |
SQE |
97-56-3 |
1-Jul-87 |
0.2 |
4-Aminobiphenyl (4-aminodiphenyl) |
cancer |
LC |
92-67-1 |
27-Feb-87 |
0.03 |
1-Amino-2,4-dibromoanthraquinone |
cancer |
AB |
81-49-2 |
26-Aug-97 |
|
3-Amino-9-ethylcarbazole hydrochloride |
cancer |
SQE |
6109-97-3 |
1-Jul-89 |
9 |
2-Aminofluorene |
cancer |
SQE |
153-78-6 |
29-Jan-99 |
|
Aminoglutethimide |
developmental |
FR |
125-84-8 |
1-Jul-90 |
|
Aminoglycosides |
developmental |
FR |
--- |
1-Oct-92 |
|
1-Amino-2-methylanthraquinone |
cancer |
LC |
82-28-0 |
1-Oct-89 |
5 |
2-Amino-5-(5-nitro-2-furyl)-1,3,4- thiadiazole |
cancer |
SQE |
712-68-5 |
1-Jul-87 |
0.04 |
4-Amino-2-nitrophenol |
cancer |
SQE |
119-34-6 |
29-Jan-99 |
|
Aminopterin |
developmental, female |
SQE |
54-62-6 |
1-Jul-87 |
|
Amiodarone hydrochloride |
developmental, female, male |
FR |
19774-82-4 |
26-Aug-97 |
|
Amitraz |
developmental |
AB |
33089-61-1 |
30-Mar-99 |
|
Amitrole |
cancer |
SQE |
61-82-5 |
1-Jul-87 |
0.7 |
Amoxapine |
developmental |
FR |
14028-44-5 |
15-May-98 |
|
Amsacrine |
cancer |
LC |
51264-14-3 |
7-Aug-09 |
|
tert-Amyl methyl ether [Delisted December 13, 2013] |
|
|
|
|
|
Anabolic steroids |
female, male |
FR |
--- |
1-Apr-90 |
|
Analgesic mixtures containing Phenacetin |
cancer |
LC |
--- |
27-Feb-87 |
|
Androstenedione |
cancer |
AB |
63-05-8 |
3-May-11 |
|
Angiotensin converting enzyme (ACE) inhibitors |
developmental |
FR |
--- |
1-Oct-92 |
|
Aniline |
cancer |
AB |
62-53-3 |
1-Jan-90 |
100 |
Aniline hydrochloride |
cancer |
AB |
142-04-1 |
15-May-98 |
|
o-Anisidine |
cancer |
SQE |
90-04-0 |
1-Jul-87 |
5 |
o-Anisidine hydrochloride |
cancer |
SQE |
134-29-2 |
1-Jul-87 |
7 |
Anisindione |
developmental |
FR |
117-37-3 |
1-Oct-92 |
|
Anthraquinone |
cancer |
AB |
84-65-1 |
28-Sep-07 |
|
Antimony oxide (Antimony trioxide) |
cancer |
AB |
1309-64-4 |
1-Oct-90 |
|
Aramite |
cancer |
SQE |
140-57-8 |
1-Jul-87 |
20 |
Areca nut |
cancer |
LC |
--- |
3-Feb-06 |
|
Aristolochic acids |
cancer |
LC |
--- |
9-Jul-04 |
|
Arsenic (inorganic arsenic compounds) |
cancer |
LC |
-- |
27-Feb-87 |
0.06
(inhalation) 10 (except
inhalation) |
Arsenic (inorganic oxides) |
developmental |
SQE |
--- |
1-May-97 |
|
Asbestos |
cancer |
LC |
1332-21-4 |
27-Feb-87 |
100
fibers/day (inhalation) |
Aspirin (NOTE: It is especially important not to use aspirin during the last three months of pregnancy, unless specifically directed to do so by a physician because it may cause problems in the unborn child or complications during delivery.) |
developmental, female |
SQE |
50-78-2 |
1-Jul-90 |
|
Atenolol |
developmental |
FR |
29122-68-7 |
26-Aug-97 |
|
Auramine |
cancer |
SQE |
492-80-8 |
1-Jul-87 |
0.8 |
Auranofin |
developmental |
FR |
34031-32-8 |
29-Jan-99 |
|
Avermectin B1 (Abamectin) |
developmental |
AB |
71751-41-2 |
3-Dec-10 |
4.4 |
Azacitidine |
cancer |
AB |
320-67-2 |
1-Jan-92 |
|
Azaserine |
cancer |
SQE |
115-02-6 |
1-Jul-87 |
0.06 |
Azathioprine |
cancer |
LC |
446-86-6 |
27-Feb-87 |
0.4 |
Azathioprine |
developmental |
FR |
446-86-6 |
1-Sep-96 |
|
Azobenzene |
cancer |
AB |
103-33-3 |
1-Jan-90 |
6 |
|
|
|
|
|
|
Barbiturates |
developmental |
FR |
--- |
1-Oct-92 |
|
Beclomethasone dipropionate |
developmental |
FR |
5534-09-8 |
15-May-98 |
|
Benomyl |
developmental, male |
SQE |
17804-35-2 |
1-Jul-91 |
|
Benthiavalicarb-isopropyl |
cancer |
AB |
177406-68-7 |
1-Jul-08 |
|
Benz[a]anthracene |
cancer |
SQE |
56-55-3 |
1-Jul-87 |
0.033 (oral) |
Benzene |
cancer |
LC |
71-43-2 |
27-Feb-87 |
6.4 (oral)
13
(inhalation) |
Benzene |
developmental, male |
SQE |
71-43-2 |
26-Dec-97 |
(inhalation) |
Benzidine [and its salts] |
cancer |
LC |
92-87-5 |
27-Feb-87 |
0.001 |
Benzidine-based dyes |
cancer |
FR |
--- |
1-Oct-92 |
|
Benzodiazepines |
developmental |
FR |
--- |
1-Oct-92 |
|
Benzo[b]fluoranthene |
cancer |
SQE |
205-99-2 |
1-Jul-87 |
0.096 (oral) |
Benzo[j]fluoranthene |
cancer |
SQE |
205-82-3 |
1-Jul-87 |
0.11 (oral) |
Benzo[k]fluoranthene |
cancer |
SQE |
207-08-9 |
1-Jul-87 |
|
Benzofuran |
cancer |
AB |
271-89-6 |
1-Oct-90 |
1.1 |
Benzophenone |
cancer |
LC |
119-61-9 |
22-Jun-12 |
|
Benzo[a]pyrene |
cancer |
SQE |
50-32-8 |
1-Jul-87 |
0.06 |
Benzotrichloride |
cancer |
SQE |
98-07-7 |
1-Jul-87 |
|
Benzphetamine hydrochloride |
developmental |
FR |
5411-22-3 |
1-Apr-90 |
|
Benzyl chloride |
cancer |
AB |
100-44-7 |
1-Jan-90 |
4 |
Benzyl violet 4B |
cancer |
SQE |
1694-09-3 |
1-Jul-87 |
30 |
Beryllium and beryllium compounds |
cancer |
SQE |
--- |
1-Oct-87 |
|
Beryllium |
|
|
|
|
0.1 |
Beryllium oxide |
|
|
|
|
0.1 |
Beryllium sulfate |
|
|
|
|
0.0002 |
Betel quid with tobacco |
cancer |
AB |
--- |
1-Jan-90 |
|
Betel quid without tobacco |
cancer |
LC |
--- |
3-Feb-06 |
|
2,2-Bis(bromomethyl)-1,3-propanediol |
cancer |
AB |
3296-90-0 |
1-May-96 |
|
Bis(2-chloroethyl)ether |
cancer |
SQE |
111-44-4 |
1-Apr-88 |
0.3 |
N,N-Bis(2-chloroethyl)-2-
naphthylamine (Chlornapazine) |
cancer |
LC |
494-03-1 |
27-Feb-87 |
|
Bischloroethyl nitrosourea (BCNU) (Carmustine) |
cancer |
SQE |
154-93-8 |
1-Jul-87 |
|
Bischloroethyl nitrosourea (BCNU) (Carmustine) |
developmental |
FR |
154-93-8 |
1-Jul-90 |
|
Bis(chloromethyl)ether |
cancer |
LC |
542-88-1 |
27-Feb-87 |
0.02 |
Bis(2-chloro-1-methylethyl)ether, technical grade |
cancer |
SQE |
--- |
29-Oct-99 |
|
Bisphenol A (BPA) [Delisted April 19, 2013] |
|
|
|
|
|
Bitumens, extracts of steam-refined and air refined |
cancer |
AB |
--- |
1-Jan-90 |
|
Bracken fern |
cancer |
AB |
--- |
1-Jan-90 |
|
Bromacil lithium salt |
developmental |
AB |
53404-19-6 |
18-May-99 |
|
Bromacil lithium salt |
male |
SQE |
53404-19-6 |
17-Jan-03 |
|
Bromate |
cancer |
AB |
15541-45-4 |
31-May-02 |
|
Bromochloroacetic acid |
cancer |
AB |
5589-96-8 |
6-Apr-10 |
|
Bromodichloromethane |
cancer |
AB |
75-27-4 |
1-Jan-90 |
5 |
Bromoethane |
cancer |
AB |
74-96-4 |
22-Dec-00 |
96 |
Bromoform |
cancer |
AB |
75-25-2 |
1-Apr-91 |
64 |
1-Bromopropane (1-BP) |
developmental, female, male |
AB |
106-94-5 |
7-Dec-04 |
|
2-Bromopropane (2-BP) |
female, male |
AB |
75-26-3 |
31-May-05 |
|
Bromoxynil |
developmental |
FR |
1689-84-5 |
1-Oct-90 |
|
Bromoxynil octanoate |
developmental |
AB |
1689-99-2 |
18-May-99 |
|
Butabarbital sodium |
developmental |
FR |
143-81-7 |
1-Oct-92 |
|
1,3-Butadiene |
cancer |
SQE |
106-99-0 |
1-Apr-88 |
0.4 |
1,3-Butadiene |
developmental, female, male |
AB |
106-99-0 |
16-Apr-04 |
|
1,4-Butanediol dimethanesulfonate (Busulfan) |
cancer |
LC |
55-98-1 |
27-Feb-87 |
|
1,4-Butanediol dimethanesulfonate (Busulfan) |
developmental |
SQE |
55-98-1 |
1-Jan-89 |
|
Butylated hydroxyanisole |
cancer |
AB |
25013-16-5 |
1-Jan-90 |
4000 |
Butyl benzyl phthalate (BBP)d |
developmental |
AB |
85-68-7 |
2-Dec-05 |
1200 (oral) |
n-Butyl glycidyl ether [Delisted April 4, 2014] |
|
|
|
|
|
beta-Butyrolactone |
cancer |
SQE |
3068-88-0 |
1-Jul-87 |
0.7 |
|
|
|
|
|
|
Cacodylic acid |
cancer |
AB |
75-60-5 |
1-May-96 |
|
Cadmium |
developmental, male |
SQE |
--- |
1-May-97 |
4.1 (oral) |
Cadmium and cadmium compounds |
cancer |
SQE |
--- |
1-Oct-87 |
|
Cadmium |
|
|
|
|
0.05
(inhalation) |
Caffeic acid |
cancer |
AB |
331-39-5 |
1-Oct-94 |
|
Captafol |
cancer |
SQE |
2425-06-1 |
1-Oct-88 |
5 |
Captan |
cancer |
AB |
133-06-2 |
1-Jan-90 |
300 |
Carbamazepine |
developmental |
FR |
298-46-4 |
29-Jan-99 |
|
Carbaryl |
cancer |
AB |
63-25-2 |
5-Feb-10 |
|
Carbaryl [Basis for listing changed effective December 27, 2013] |
developmental, female, male |
AB |
63-25-2 |
7-Aug-09 |
|
Carbazole |
cancer |
AB |
86-74-8 |
1-May-96 |
4.1 |
Carbon black (airborne, unbound particles of respirable size) |
cancer |
AB |
1333-86-4 |
21-Feb-03 |
|
Carbon disulfide |
developmental, female, male |
SQE |
75-15-0 |
1-Jul-89 |
|
Carbon monoxide |
developmental |
SQE |
630-08-0 |
1-Jul-89 |
|
Carbon tetrachloride |
cancer |
SQE |
56-23-5 |
1-Oct-87 |
5 |
Carbon-black extracts |
cancer |
AB |
--- |
1-Jan-90 |
|
Carboplatin |
developmental |
FR |
41575-94-4 |
1-Jul-90 |
|
N-Carboxymethyl-N-nitrosourea |
cancer |
SQE |
60391-92-6 |
25-Jan-02 |
0.7 |
Catechol |
cancer |
AB |
120-80-9 |
15-Jul-03 |
|
Ceramic fibers (airborne particles of respirable size) |
cancer |
AB |
--- |
1-Jul-90 |
|
Certain combined chemotherapy for lymphomas |
cancer |
LC |
--- |
27-Feb-87 |
|
Chenodiol |
developmental |
FR |
474-25-9 |
1-Apr-90 |
|
Chloral |
cancer |
LC |
75-87-6 |
13-Sep-13 |
|
Chloral hydrate |
cancer |
LC |
302-17-0 |
13-Sep-13 |
|
Chlorambucil |
cancer |
LC |
305-03-3 |
27-Feb-87 |
0.002 |
Chlorambucil |
developmental |
SQE |
305-03-3 |
1-Jan-89 |
|
Chloramphenicol [Delisted January 4, 2013] |
|
|
|
|
|
Chloramphenicol sodium succinate |
cancer |
FR |
982-57-0 |
27-Sep-13 |
|
Chlorcyclizine hydrochloride |
developmental |
FR |
1620-21-9 |
1-Jul-87 |
|
Chlordane |
cancer |
SQE |
57-74-9 |
1-Jul-88 |
0.5 |
Chlordecone (Kepone) |
cancer |
SQE |
143-50-0 |
1-Jan-88 |
0.04 |
Chlordecone (Kepone) |
developmental |
SQE |
143-50-0 |
1-Jan-89 |
|
Chlordiazepoxide |
developmental |
FR |
58-25-3 |
1-Jan-92 |
|
Chlordiazepoxide hydrochloride |
developmental |
FR |
438-41-5 |
1-Jan-92 |
|
Chlordimeform |
cancer |
SQE |
6164-98-3 |
1-Jan-89 |
|
Chlorendic acid |
cancer |
SQE |
115-28-6 |
1-Jul-89 |
8 |
Chlorinated paraffins (Average chain length, C12;approximately 60 percent chlorine by weight) |
cancer |
SQE |
108171-26-2 |
1-Jul-89 |
8 |
p-Chloroaniline |
cancer |
AB |
106-47-8 |
1-Oct-94 |
1.5 |
p-Chloroaniline hydrochloride |
cancer |
AB |
20265-96-7 |
15-May-98 |
1.9 |
Chlorodibromomethane [Delisted October 29, 1999] |
|
|
|
|
|
Chloroethane (Ethyl chloride) |
cancer |
AB |
75-00-3 |
1-Jul-90 |
150 |
1-(2-Chloroethyl)-3-cyclohexyl-1- nitrosourea (CCNU) (Lomustine) |
cancer |
SQE |
13010-47-4 |
1-Jan-88 |
|
1-(2-Chloroethyl)-3-cyclohexyl-1- nitrosourea (CCNU) (Lomustine) |
developmental |
FR |
13010-47-4 |
1-Jul-90 |
|
1-(2-Chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea
(Methyl-CCNU) |
cancer |
SQE |
13909-09-6 |
1-Oct-88 |
|
Chloroform |
cancer |
SQE |
67-66-3 |
1-Oct-87 |
20 (oral)
40
(inhalation) |
Chloroform |
developmental |
LC |
67-66-3 |
7-Aug-09 |
|
Chloromethyl methyl ether (technical grade) |
cancer |
LC |
107-30-2 |
27-Feb-87 |
0.3 |
3-Chloro-2-methylpropene |
cancer |
SQE |
563-47-3 |
1-Jul-89 |
5 |
1-Chloro-4-nitrobenzene |
cancer |
SQE |
100-00-5 |
29-Oct-99 |
|
4-Chloro-o-phenylenediamine |
cancer |
SQE |
95-83-0 |
1-Jan-88 |
40 |
Chloroprene |
cancer |
AB |
126-99-8 |
2-Jun-00 |
|
2-Chloropropionic acid [Basis for listing changed effective December 20, 2013] |
male |
SQE |
598-78-7 |
7-Aug-09 |
|
Chlorothalonil |
cancer |
SQE |
1897-45-6 |
1-Jan-89 |
41 |
p-Chloro-o-toluidine |
cancer |
AB |
95-69-2 |
1-Jan-90 |
3 |
p-Chloro-o-toluidine, strong acid salts of |
cancer |
AB |
--- |
15-May-98 |
|
p-Chloro-o-toluidine, hydrochloride |
|
|
|
|
3.3 |
5-Chloro-o-toluidine and its strong acid salts |
cancer |
SQE |
--- |
24-Oct-97 |
|
Chlorotrianisene |
cancer |
FR |
569-57-3 |
1-Sep-96 |
|
Chlorozotocin |
cancer |
AB |
54749-90-5 |
1-Jan-92 |
0.003 |
Chlorsulfuron [Delisted June 6, 2014] |
|
|
|
14-May-99 |
|
Chromium (hexavalent compounds) |
cancer |
LC |
--- |
27-Feb-87 |
0.001
(inhalation) |
Chromium (hexavalent compounds) |
developmental, female, male |
SQE |
--- |
19-Dec-08 |
8.2 (oral) |
Chrysene |
cancer |
AB |
218-01-9 |
1-Jan-90 |
0.35 (oral) |
C.I. Acid Red 114 |
cancer |
AB |
6459-94-5 |
1-Jul-92 |
|
C.I. Basic Red 9 monohydrochloride |
cancer |
SQE |
569-61-9 |
1-Jul-89 |
3 |
C.I. Direct Blue 15 |
cancer |
AB |
2429-74-5 |
26-Aug-97 |
|
C.I. Direct Blue 218 |
cancer |
AB |
28407-37-6 |
26-Aug-97 |
50 |
C.I. Disperse Yellow 3 |
cancer |
SQE |
2832-40-8 |
8-Feb-13 |
|
C.I. Solvent Yellow 14 |
cancer |
AB |
842-07-9 |
15-May-98 |
|
Ciclosporin (Cyclosporin A; Cyclosporine) |
cancer |
AB |
59865-13-3;
79217-60-0 |
1-Jan-92 |
|
Cidofovir |
cancer, developmental, female, male |
FR |
113852-37-2 |
29-Jan-99 |
|
Cinnamyl anthranilate |
cancer |
SQE |
87-29-6 |
1-Jul-89 |
200 |
Cisplatin |
cancer |
SQE |
15663-27-1 |
1-Oct-88 |
|
Citrus Red No. 2 |
cancer |
LC |
6358-53-8 |
1-Oct-89 |
|
Cladribine |
developmental |
FR |
4291-63-8 |
1-Sep-96 |
|
Clarithromycin |
developmental |
FR |
81103-11-9 |
1-May-97 |
|
Clobetasol propionate |
developmental,
female |
FR |
25122-46-7 |
15-May-98 |
|
Clofibrate |
cancer |
FR |
637-07-0 |
1-Sep-96 |
|
Clomiphene citrate |
cancer |
FR |
50-41-9 |
24-May-13 |
|
Clomiphene citrate |
developmental |
FR |
50-41-9 |
1-Apr-90 |
|
Clorazepate dipotassium |
developmental |
FR |
57109-90-7 |
1-Oct-92 |
|
Cobalt metal powder |
cancer |
AB |
7440-48-4 |
1-Jul-92 |
|
Cobalt [II] oxide |
cancer |
AB |
1307-96-6 |
1-Jul-92 |
|
Cobalt sulfate |
cancer |
LC |
10124-43-3 |
20-May-05 |
|
Cobalt sulfate heptahydrate |
cancer |
AB |
10026-24-1 |
2-Jun-00 |
|
Cocaine |
developmental,
female |
SQE |
50-36-2 |
1-Jul-89 |
|
Coconut oil diethanolamine condensate (cocamide diethanolamine) |
cancer |
LC |
68603-42-9 |
22-Jun-12 |
|
Codeine phosphate |
developmental |
FR |
52-28-8 |
15-May-98 |
|
Coke oven emissions |
cancer |
LC |
--- |
27-Feb-87 |
0.3 |
Colchicine |
developmental, male |
FR |
64-86-8 |
1-Oct-92 |
|
Conjugated estrogens |
cancer |
LC |
--- |
27-Feb-87 |
|
Conjugated estrogens |
developmental |
FR |
--- |
1-Apr-90 |
|
Creosotes |
cancer |
SQE |
--- |
1-Oct-88 |
|
p-Cresidine |
cancer |
SQE |
120-71-8 |
1-Jan-88 |
5 |
Cumene |
cancer |
AB |
98-82-8 |
6-Apr-10 |
|
Cupferron |
cancer |
SQE |
135-20-6 |
1-Jan-88 |
3 |
Cyanazine |
developmental |
FR |
21725-46-2 |
1-Apr-90 |
|
Cycasin |
cancer |
SQE |
14901-08-7 |
1-Jan-88 |
|
Cycloate |
developmental |
AB |
1134-23-2 |
19-Mar-99 |
|
Cyclohexanol [Delisted January 25, 2002] |
|
|
|
|
|
Cycloheximide |
developmental |
FR |
66-81-9 |
1-Jan-89 |
|
Cyclopenta[cd]pyrene |
cancer |
LC |
27208-37-3 |
29-Apr-11 |
|
Cyclophosphamide (anhydrous) |
cancer |
LC |
50-18-0 |
27-Feb-87 |
1 |
Cyclophosphamide (anhydrous) |
developmental, female, male |
SQE -
development al FR - female, male |
50-18-0 |
1-Jan-89 |
|
Cyclophosphamide (hydrated) |
cancer |
LC |
6055-19-2 |
27-Feb-87 |
1 |
Cyclophosphamide (hydrated) |
developmental, female, male |
SQE -
development alFR - female, male |
6055-19-2 |
1-Jan-89 |
|
Cyhexatin |
developmental |
FR |
13121-70-5 |
1-Jan-89 |
|
Cytarabine |
developmental |
SQE |
147-94-4 |
1-Jan-89 |
|
Cytembena |
cancer |
AB |
21739-91-3 |
15-May-98 |
|
|
|
|
|
|
|
D&C Orange No. 17 |
cancer |
AB |
3468-63-1 |
1-Jul-90 |
|
D&C Red No. 8 |
cancer |
AB |
2092-56-0 |
1-Oct-90 |
|
D&C Red No. 9 |
cancer |
AB |
5160-02-1 |
1-Jul-90 |
100 |
D&C Red No. 19 |
cancer |
AB |
81-88-9 |
1-Jul-90 |
|
Dacarbazine |
cancer |
SQE |
4342-03-4 |
1-Jan-88 |
0.01 |
Dacarbazine |
developmental |
FR |
4342-03-4 |
29-Jan-99 |
|
Daminozide |
cancer |
AB |
1596-84-5 |
1-Jan-90 |
40 |
Danazol |
developmental |
FR |
17230-88-5 |
1-Apr-90 |
|
Dantron (Chrysazin; 1,8- Dihydroxyanthraquinone) |
cancer |
AB |
117-10-2 |
1-Jan-92 |
9 |
Daunomycin |
cancer |
SQE |
20830-81-3 |
1-Jan-88 |
|
Daunorubicin hydrochloride |
developmental |
FR |
23541-50-6 |
1-Jul-90 |
|
2,4-D butyric acid [Basis for the removal of developmental endpoint effective June 22, 2001] |
male |
AB |
94-82-6 |
18-Jun-99 |
910 |
DDD (Dichlorodiphenyl- dichloroethane) |
cancer |
SQE |
72-54-8 |
1-Jan-89 |
2 (DDT, DDE, DDD in combinatio n) |
DDE (Dichlorodiphenyl- dichloroethylene) |
cancer |
SQE |
72-55-9 |
1-Jan-89 |
2 (DDT, DDE, DDD in combinatio |
DDT (Dichlorodiphenyl- trichloroethane) |
cancer |
SQE |
50-29-3 |
1-Oct-87 |
2 (DDT, DDE, DDD in combination) |
o,p'-DDT |
developmental, female, male |
AB |
789-02-6 |
15-May-98 |
|
p,p'-DDT |
developmental, female, male |
AB |
50-29-3 |
15-May-98 |
|
DDVP (Dichlorvos) |
cancer |
SQE |
62-73-7 |
1-Jan-89 |
2 |
2,4-DP (dichloroprop) [Delisted January 25, 2002] |
|
|
|
|
|
Demeclocycline hydrochloride (internal use) |
developmental |
FR |
64-73-3 |
1-Jan-92 |
|
N,N'-Diacetylbenzidine |
cancer |
LC |
613-35-4 |
1-Oct-89 |
|
2,4-Diaminoanisole |
cancer |
FR |
615-05-4 |
1-Oct-90 |
30 |
2,4-Diaminoanisole sulfate |
cancer |
SQE |
39156-41-7 |
1-Jan-88 |
50 |
4,4'-Diaminodiphenyl ether (4,4'- Oxydianiline) |
cancer |
SQE |
101-80-4 |
1-Jan-88 |
5 |
2,4-Diaminotoluene |
cancer |
SQE |
95-80-7 |
1-Jan-88 |
0.2 |
Diaminotoluene (mixed) |
cancer |
AB |
--- |
1-Jan-90 |
|
Diazepam |
developmental |
FR |
439-14-5 |
1-Jan-92 |
|
Diazoaminobenzene |
cancer |
LC |
136-35-6 |
20-May-05 |
|
Diazoxide |
developmental |
FR |
364-98-7 |
27-Feb-01 |
|
Dibenz[a,h]acridine |
cancer |
SQE |
226-36-8 |
1-Jan-88 |
|
Dibenz[a,j]acridine |
cancer |
SQE |
224-42-0 |
1-Jan-88 |
|
Dibenz[a,h]anthracene |
cancer |
SQE |
53-70-3 |
1-Jan-88 |
0.2 |
7H-Dibenzo[c,g]carbazole |
cancer |
SQE |
194-59-2 |
1-Jan-88 |
0.0030
(oral) |
Dibenzo[a,e]pyrene |
cancer |
SQE |
192-65-4 |
1-Jan-88 |
|
Dibenzo[a,h]pyrene |
cancer |
SQE |
189-64-0 |
1-Jan-88 |
0.0054
(oral) |
Dibenzo[a,i]pyrene |
cancer |
SQE |
189-55-9 |
1-Jan-88 |
0.0050
(oral) |
Dibenzo[a,l]pyrene |
cancer |
SQE |
191-30-0 |
1-Jan-88 |
|
Dibromoacetic acid |
cancer |
AB |
631-64-1 |
17-Jun-08 |
|
Dibromoacetonitrile |
cancer |
AB |
3252-43-5 |
3-May-11 |
|
1,2-Dibromo-3-chloropropane (DBCP) |
cancer |
FR |
96-12-8 |
1-Jul-87 |
0.1 |
1,2-Dibromo-3-chloropropane (DBCP)
[Basis for listing changed effective November 22, 2013] |
male |
FR |
96-12-8 |
27-Feb-87 |
3.1 (oral)
4.3 (inhalation) |
2,3-Dibromo-1-propanol |
cancer |
AB |
96-13-9 |
1-Oct-94 |
|
Dichloroacetic acid |
cancer |
AB |
79-43-6 |
1-May-96 |
|
Dichloroacetic acid |
developmental, male |
AB |
79-43-6 |
7-Aug-09 |
|
p-Dichlorobenzene |
cancer |
SQE |
106-46-7 |
1-Jan-89 |
20 |
3,3'-Dichlorobenzidine |
cancer |
SQE |
91-94-1 |
1-Oct-87 |
0.6 |
3,3'-Dichlorobenzidine dihydrochloride |
cancer |
AB |
612-83-9 |
15-May-98 |
|
1,1-Dichloro-2,2-bis(p- chloropheny)ethylene (DDE) |
developmental, male |
AB |
72-55-9 |
30-Mar-10 |
|
1,4-Dichloro-2-butene |
cancer |
AB |
764-41-0 |
1-Jan-90 |
|
3,3'-Dichloro-4,4'-diamino-diphenyl ether |
cancer |
SQE |
28434-86-8 |
1-Jan-88 |
|
1,1-Dichloroethane |
cancer |
AB |
75-34-3 |
1-Jan-90 |
100 |
Dichloromethane (Methylene chloride) |
cancer |
SQE |
75-09-2 |
1-Apr-88 |
50
200
(inhalation) |
Dichlorophene |
developmental |
AB |
97-23-4 |
27-Apr-99 |
|
Dichlorphenamide |
developmental |
FR |
120-97-8 |
27-Feb-01 |
|
1,2-Dichloropropane |
cancer |
AB |
78-87-5 |
1-Jan-90 |
9.7 |
1,3-Dichloro-2-propanol (1,3-DCP) |
cancer |
SQE |
96-23-1 |
8-Oct-10 |
|
1,3-Dichloropropene |
cancer |
SQE |
542-75-6 |
1-Jan-89 |
|
Diclofop-methyl |
cancer |
AB |
51338-27-3 |
6-Apr-10 |
|
Diclofop methyl |
developmental |
AB |
51338-27-3 |
5-Mar-99 |
|
Dicumarol |
developmental |
FR |
66-76-2 |
1-Oct-92 |
|
Dieldrin |
cancer |
SQE |
60-57-1 |
1-Jul-88 |
0.04 |
Dienestrol [Delisted January 4, 2013] |
|
|
|
|
|
Diepoxybutane |
cancer |
SQE |
1464-53-5 |
1-Jan-88 |
|
Diesel engine exhaust |
cancer |
AB |
--- |
1-Oct-90 |
|
Diethanolamine |
cancer |
LC |
111-42-2 |
22-Jun-12 |
|
Di(2-ethylhexyl)phthalate |
cancer |
SQE |
117-81-7 |
1-Jan-88 |
310 |
Di(2-ethylhexyl)phthalate |
developmental, male |
AB |
117-81-7 |
24-Oct-03 |
|
Adultb |
|
- |
|
|
4200 (intravenou s) |
Infant boys, age 29 days to 24 monthsb |
|
- |
|
|
600 (intravenou s) |
Neonatal infant boys, age 0 to 28 daysb |
|
- |
|
|
210 (intravenous) |
Adultb |
|
- |
|
|
410 (oral) |
Infant boys, age 29 days to 24 monthsb |
|
- |
|
|
58 (oral) |
Neonatal infant boys, age 0 to 28 daysb |
|
- |
|
|
20 (oral) |
1,2-Diethylhydrazine |
cancer |
SQE |
1615-80-1 |
1-Jan-88 |
|
Diethylstilbestrol (DES) |
cancer |
LC |
56-53-1 |
27-Feb-87 |
0.002 |
Diethylstilbestrol (DES) |
developmental |
FR |
56-53-1 |
1-Jul-87 |
|
Diethyl sulfate |
cancer |
SQE |
64-67-5 |
1-Jan-88 |
|
Diflunisal |
developmental, female |
FR |
22494-42-4 |
29-Jan-99 |
|
Diglycidyl ether [Delisted April 4, 2014] |
|
|
|
|
|
Diglycidyl resorcinol ether (DGRE) |
cancer |
SQE |
101-90-6 |
1-Jul-89 |
0.4 |
Dihydroergotamine mesylate |
developmental |
FR |
6190-39-2 |
1-May-97 |
|
Dihydrosafrole |
cancer |
SQE |
94-58-6 |
1-Jan-88 |
20 |
Diisononyl phthalate (DINP) |
cancer |
SQE |
--- |
20-Dec-13 |
|
Diisopropyl sulfate |
cancer |
AB |
2973-10-6 |
1-Apr-93 |
|
|
|
|
68515-49-1/ |
|
|
Di-isodecyl phthalate (DIDP) |
developmental |
AB |
26761-40-0 |
20-Apr-07 |
2200 |
Diltiazem hydrochloride |
developmental |
FR |
33286-22-5 |
27-Feb-01 |
|
3,3'-Dimethoxybenzidine (o- Dianisidine) |
cancer |
SQE |
119-90-4 |
1-Jan-88 |
0.15 |
3,3'-Dimethoxybenzidine dihydrochloride |
cancer |
AB |
20325-40-0 |
1-Oct-90 |
0.19 |
3,3'-Dimethoxybenzidine-based dyes metabolized to 3,3'-dimethoxybenzidine |
cancer |
AB |
--- |
11-Jun-04 |
|
N,N-Dimethylacetamide [Basis for addition of male reproductive endpoint effective December 20, 2013] |
developmental, male |
SQE |
127-19-5 |
21-May-10 |
|
4-Dimethylaminoazobenzene |
cancer |
SQE |
60-11-7 |
1-Jan-88 |
0.2 |
trans-2-
[(Dimethylamino)methylimino]-5-[2-(5- nitro-2-furyl)vinyl]-1,3,4-oxadiazole |
cancer |
SQE |
55738-54-0 |
1-Jan-88 |
2 |
7,12-Dimethylbenz(a)anthracene |
cancer |
AB |
57-97-6 |
1-Jan-90 |
0.003 |
3,3'-Dimethylbenzidine (ortho-Tolidine) |
cancer |
SQE |
119-93-7 |
1-Jan-88 |
0.044 |
3,3'-Dimethylbenzidine dihydrochloride |
cancer |
AB |
612-82-8 |
1-Apr-92 |
0.059 |
3,3'-Dimethylbenzidine-based dyes metabolized to 3,3'-dimethylbenzidine |
cancer |
AB |
--- |
11-Jun-04 |
|
Dimethylcarbamoyl chloride |
cancer |
SQE |
79-44-7 |
1-Jan-88 |
0.05 |
1,1-Dimethylhydrazine (UDMH) |
cancer |
LC |
57-14-7 |
1-Oct-89 |
|
1,2-Dimethylhydrazine |
cancer |
SQE |
540-73-8 |
1-Jan-88 |
0.001 |
2,6-Dimethyl-N-nitrosomorpholine (DMNM) |
cancer |
SQE |
1456-28-6 |
8-Feb-13 |
|
Dimethyl sulfate |
cancer |
SQE |
77-78-1 |
1-Jan-88 |
|
N,N-Dimethyl-p-toluidine |
cancer |
AB |
99-97-8 |
2-May-14 |
|
Dimethylvinylchloride |
cancer |
SQE |
513-37-1 |
1-Jul-89 |
20 |
Di-n-butyl phthalate (DBP) |
developmental, female, male |
AB |
84-74-2 |
2-Dec-05 |
8.7 |
Di-n-hexyl phthalate (DnHP) |
female, male |
AB |
84-75-3 |
2-Dec-05 |
2200 (oral) |
m-Dinitrobenzene |
male |
AB |
99-65-0 |
1-Jul-90 |
38 |
o-Dinitrobenzene |
male |
AB |
528-29-0 |
1-Jul-90 |
|
p-Dinitrobenzene |
male |
AB |
100-25-4 |
1-Jul-90 |
|
3,7-Dinitrofluoranthene |
cancer |
AB |
105735-71-5 |
26-Aug-97 |
|
3,9-Dinitrofluoranthene |
cancer |
AB |
22506-53-2 |
26-Aug-97 |
|
1,3-Dinitropyrene |
cancer |
LC |
75321-20-9 |
2-Nov-12 |
|
1,6-Dinitropyrene |
cancer |
AB |
42397-64-8 |
1-Oct-90 |
|
1,8-Dinitropyrene |
cancer |
AB |
42397-65-9 |
1-Oct-90 |
|
2,4-Dinitrotoluene |
cancer |
SQE |
121-14-2 |
1-Jul-88 |
2 |
2,4-Dinitrotoluene |
male |
AB |
121-14-2 |
20-Aug-99 |
|
2,6-Dinitrotoluene |
cancer |
SQE |
606-20-2 |
1-Jul-95 |
|
2,6-Dinitrotoluene |
male |
AB |
606-20-2 |
20-Aug-99 |
|
Dinitrotoluene (technical grade) |
female, male |
AB |
--- |
20-Aug-99 |
|
Dinitrotoluene mixture, 2,4-/2,6- |
cancer |
AB |
--- |
1-May-96 |
|
Dinocap |
developmental |
FR |
39300-45-3 |
1-Apr-90 |
|
Dinoseb |
developmental,
male |
FR |
88-85-7 |
1-Jan-89 |
|
Di-n-propyl isocinchomeronate (MGK Repellent 326) |
cancer |
AB |
136-45-8 |
1-May-96 |
|
1,4-Dioxane |
cancer |
SQE |
123-91-1 |
1-Jan-88 |
30 |
Diphenylhydantoin (Phenytoin) |
cancer |
SQE |
57-41-0 |
1-Jan-88 |
|
Diphenylhydantoin (Phenytoin) |
developmental |
SQE |
57-41-0 |
1-Jul-87 |
|
Diphenylhydantoin (Phenytoin), sodium salt |
cancer |
SQE |
630-93-3 |
1-Jan-88 |
|
Direct Black 38 (technical grade) |
cancer |
SQE |
1937-37-7 |
1-Jan-88 |
0.09 |
Direct Blue 6 (technical grade) |
cancer |
SQE |
2602-46-2 |
1-Jan-88 |
0.09 |
Direct Brown 95 (technical grade) |
cancer |
SQE |
16071-86-6 |
1-Oct-88 |
0.1 |
Disodium cyanodithioimidocarbonate |
developmental |
AB |
138-93-2 |
30-Mar-99 |
56 (oral)
170 (oral) as 32%
pesticidal formulation |
Disperse Blue 1 |
cancer |
AB |
2475-45-8 |
1-Oct-90 |
200 |
Diuron |
cancer |
AB |
330-54-1 |
31-May-02 |
|
Doxorubicin hydrochloride (Adriamycin) |
cancer |
SQE |
25316-40-9 |
1-Jul-87 |
|
Doxorubicin hydrochloride (Adriamycin) |
developmental, male |
FR |
25316-40-9 |
29-Jan-99 |
|
Doxycycline (internal use) |
developmental |
FR |
564-25-0 |
1-Jul-90 |
|
Doxycycline calcium (internal use) |
developmental |
FR |
94088-85-4 |
1-Jan-92 |
|
Doxycycline hyclate (internal use) |
developmental |
FR |
24390-14-5 |
1-Oct-91 |
|
Doxycycline monohydrate (internal use) |
developmental |
FR |
17086-28-1 |
1-Oct-91 |
|
Emissions from combustion of coal |
cancer |
AB |
--- |
7-Aug-13 |
|
Emissions from high-temperature unrefined rapeseed oil |
cancer |
AB |
--- |
3-Jan-14 |
|
Endrin |
developmental |
AB |
72-20-8 |
15-May-98 |
|
Environmental tobacco smoke (ETS) |
developmental |
SQE |
--- |
9-Jun-06 |
|
Epichlorohydrin |
cancer |
SQE |
106-89-8 |
1-Oct-87 |
9 |
Epichlorohydrin |
male |
AB |
106-89-8 |
1-Sep-96 |
|
Epoxiconazole |
cancer |
AB |
135319-73-2 |
15-Apr-11 |
|
Ergotamine tartrate |
developmental |
FR |
379-79-3 |
1-Apr-90 |
|
Erionite |
cancer |
SQE |
12510-42-8;
66733-21-9 |
1-Oct-88 |
|
Estradiol 17B |
cancer |
SQE |
50-28-2 |
1-Jan-88 |
0.02 |
Estragole |
cancer |
SQE |
140-67-0 |
29-Oct-99 |
|
Estrogens, steroidal |
cancer |
LC |
--- |
19-Aug-05 |
|
Estrogen-progestogen (combined) used as menopausal therapy |
cancer |
LC |
--- |
4-Nov-11 |
|
Estrone |
cancer |
SQE |
53-16-7 |
1-Jan-88 |
|
Estropipate |
cancer, developmental |
FR |
7280-37-7 |
26-Aug-97 |
|
Ethanol in alcoholic beverages |
cancer |
LC |
--- |
29-Apr-11 |
|
Ethinylestradiol |
cancer |
SQE |
57-63-6 |
1-Jan-88 |
|
Ethionamide |
developmental |
FR |
536-33-4 |
26-Aug-97 |
|
Ethoprop |
cancer |
AB |
13194-48-4 |
27-Feb-01 |
|
Ethyl acrylate |
cancer |
SQE |
140-88-5 |
1-Jul-89 |
|
Ethyl alcohol in alcoholic beverages |
developmental |
SQE |
--- |
1-Oct-87 |
|
Ethylbenzene |
cancer |
AB |
100-41-4 |
11-Jun-04 |
54
(inhalation) 41 (oral) |
Ethyl-tert-butyl ether [Delisted December 13, 2013] |
|
|
|
|
|
Ethyl dipropylthiocarbamate |
developmental |
AB |
759-94-4 |
27-Apr-99 |
700 (oral
and inhalation)
6700
(dermal) |
Ethyl-4,4'-dichlorobenzilate |
cancer |
AB |
510-15-6 |
1-Jan-90 |
7 |
Ethylene dibromide |
cancer |
FR |
106-93-4 |
1-Jul-87 |
0.2 (oral)
3
(inhalation) |
Ethylene dibromide |
developmental, male |
AB |
106-93-4 |
15-May-98 |
|
Ethylene dichloride (1,2- Dichloroethane) |
cancer |
SQE |
107-06-2 |
1-Oct-87 |
10 |
Ethylene glycol monoethyl ether |
developmental, male |
SQE |
110-80-5 |
1-Jan-89 |
750 (oral)
960 (inhalation) |
Ethylene glycol monoethyl ether acetate |
developmental, male |
AB |
111-15-9 |
1-Jan-93 |
1100 (oral)
1400 (inhalation) |
Ethylene glycol monomethyl ether |
developmental,
male |
SQE |
109-86-4 |
1-Jan-89 |
63 (oral) |
Ethylene glycol monomethyl ether acetate |
developmental, male |
AB |
110-49-6 |
1-Jan-93 |
98 (oral) |
Ethyleneimine |
cancer |
SQE |
151-56-4 |
1-Jan-88 |
0.01 |
Ethylene oxide |
cancer |
FR |
75-21-8 |
1-Jul-87 |
2 |
Ethylene oxide [Basis for listing changed effective November 22, 2013] |
female |
FR |
75-21-8 |
27-Feb-87 |
20 |
Ethylene oxide [Basis for listing changed effective November 22, 2013] |
developmental, male |
FR |
75-21-8 |
7-Aug-09 |
|
Ethylene thiourea |
cancer |
AB |
96-45-7 |
1-Jan-88 |
20 |
Ethylene thiourea |
developmental |
SQE |
96-45-7 |
1-Jan-93 |
|
2-Ethylhexanoic acid [Delisted December 13, 2013] |
|
|
|
|
|
Ethyl methanesulfonate |
cancer |
SQE |
62-50-0 |
1-Jan-88 |
|
Etodolac |
developmental, female |
FR |
41340-25-4 |
20-Aug-99 |
|
Etoposide |
cancer |
LC |
33419-42-0 |
4-Nov-11 |
|
Etoposide |
developmental |
FR |
33419-42-0 |
1-Jul-90 |
|
Etoposide in combination with cisplatin and bleomycin |
cancer |
LC |
--- |
4-Nov-11 |
|
Etretinate |
developmental |
SQE |
54350-48-0 |
1-Jul-87 |
|
Fenoxaprop ethyl |
developmental |
AB |
66441-23-4 |
26-Mar-99 |
|
Fenoxycarb |
cancer |
AB |
72490-01-8 |
2-Jun-00 |
|
Filgrastim |
developmental |
FR |
121181-53-1 |
27-Feb-01 |
|
Fluazifop butyl |
developmental |
AB |
69806-50-4 |
6-Nov-98 |
|
Flunisolide |
developmental, female |
FR |
3385-03-3 |
15-May-98 |
|
Fluorouracil |
developmental |
SQE |
51-21-8 |
1-Jan-89 |
|
Fluoxymesterone |
developmental |
FR |
76-43-7 |
1-Apr-90 |
|
Flurazepam hydrochloride |
developmental |
FR |
1172-18-5 |
1-Oct-92 |
|
Flurbiprofen |
developmental,
female |
FR |
5104-49-4 |
20-Aug-99 |
|
Flutamide |
developmental |
FR |
13311-84-7 |
1-Jul-90 |
|
Fluticasone propionate |
developmental |
FR |
80474-14-2 |
15-May-98 |
|
Fluvalinate |
developmental |
AB |
69409-94-5 |
6-Nov-98 |
|
Folpet |
cancer |
SQE |
133-07-3 |
1-Jan-89 |
200 |
Formaldehyde (gas) |
cancer |
SQE |
50-00-0 |
1-Jan-88 |
40 |
2-(2-Formylhydrazino)-4-(5-nitro-2- furyl)thiazole |
cancer |
SQE |
3570-75-0 |
1-Jan-88 |
0.3 |
Fumonisin B1 |
cancer |
AB |
116355-83-0 |
14-Nov-03 |
|
Furan |
cancer |
AB |
110-00-9 |
1-Oct-93 |
|
Furazolidone |
cancer |
AB |
67-45-8 |
1-Jan-90 |
|
Furmecyclox |
cancer |
AB |
60568-05-0 |
1-Jan-90 |
20 |
Fusarin C |
cancer |
SQE |
79748-81-5 |
1-Jul-95 |
|
Gallium arsenide |
cancer |
LC |
1303-00-0 |
1-Aug-08 |
|
Ganciclovir |
cancer,
developmental, male |
FR |
82410-32-0 |
26-Aug-97 |
|
Ganciclovir sodium |
developmental, male |
FR |
107910-75-8 |
26-Aug-97 |
|
Gasoline engine exhaust (condensates/extracts) |
cancer |
AB |
--- |
1-Oct-90 |
|
Gemfibrozil |
cancer |
FR |
25812-30-0 |
22-Dec-00 |
|
Gemfibrozil |
female, male |
FR |
25812-30-0 |
20-Aug-99 |
|
Glass wool fibers (inhalable and biopersistent) |
cancer |
AB |
--- |
1-Jul-90 |
|
Glu-P-1 (2-Amino-6- methyldipyrido[1,2- a:3',2'-d]imidazole) |
cancer |
AB |
67730-11-4 |
1-Jan-90 |
0.1 |
Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'- d]imidazole) |
cancer |
AB |
67730-10-3 |
1-Jan-90 |
0.5 |
Glycidaldehyde |
cancer |
SQE |
765-34-4 |
1-Jan-88 |
|
Glycidol |
cancer |
AB |
556-52-5 |
1-Jul-90 |
0.54 |
Goserelin acetate |
developmental, female, male |
FR |
65807-02-5 |
26-Aug-97 |
|
Griseofulvin |
cancer |
AB |
126-07-8 |
1-Jan-90 |
|
Gyromitrin (Acetaldehyde methylformylhydrazone) |
cancer |
SQE |
16568-02-8 |
1-Jan-88 |
0.07 |
Halazepam |
developmental |
FR |
23092-17-3 |
1-Jul-90 |
|
Halobetasol propionate |
developmental |
FR |
66852-54-8 |
20-Aug-99 |
|
Haloperidol |
developmental, female |
FR |
52-86-8 |
29-Jan-99 |
|
Halothane |
developmental |
FR |
151-67-7 |
1-Sep-96 |
|
HC Blue 1 |
cancer |
SQE |
2784-94-3 |
1-Jul-89 |
10 |
Heptachlor |
cancer |
SQE |
76-44-8 |
1-Jul-88 |
0.2 |
Heptachlor |
developmental |
AB |
76-44-8 |
20-Aug-99 |
|
Heptachlor epoxide |
cancer |
SQE |
1024-57-3 |
1-Jul-88 |
0.08 |
Herbal remedies containing plant species of the genus Aristolochia |
cancer |
LC |
--- |
9-Jul-04 |
|
Hexachlorobenzene |
cancer |
SQE |
118-74-1 |
1-Oct-87 |
0.4 |
Hexachlorobenzene |
developmental |
SQE |
118-74-1 |
1-Jan-89 |
|
Hexachlorobutadiene |
cancer |
AB |
87-68-3 |
3-May-11 |
|
Hexachlorocyclohexane (technical grade) |
cancer |
SQE |
--- |
1-Oct-87 |
0.2 |
Hexachlorocyclohexane (alpha isomer) |
|
|
|
|
0.3 |
Hexachlorocyclohexane (beta isomer) |
|
|
|
|
0.5 |
Hexachlorocyclohexane (gamma isomer) |
|
|
|
|
0.6 |
Hexachlorodibenzodioxin |
cancer |
SQE |
34465-46- 8 |
1-Apr-88 |
0.0002 |
Hexachloroethane |
cancer |
AB |
67-72-1 |
1-Jul-90 |
20 |
2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) |
cancer |
AB |
--- |
4-Mar-05 |
|
Hexafluoroacetone [Basis for listing changed effective June 6, 2014] |
developmental, male |
SQE |
684-16-2 |
1-Aug-08 |
|
Hexamethylphosphoramide |
cancer |
SQE |
680-31-9 |
1-Jan-88 |
|
Hexamethylphosphoramide |
male |
AB |
680-31-9 |
1-Oct-94 |
|
Histrelin acetate |
developmental |
FR |
--- |
15-May-98 |
|
Hydramethylnon |
developmental, male |
AB |
67485-29-4 |
5-Mar-99 |
120 (oral) |
Hydrazine |
cancer |
SQE |
302-01-2 |
1-Jan-88 |
0.04 |
Hydrazine sulfate |
cancer |
SQE |
10034-93-2 |
1-Jan-88 |
0.2 |
Hydrazobenzene (1,2- Diphenylhydrazine) |
cancer |
SQE |
122-66-7 |
1-Jan-88 |
0.8 |
Hydrogen cyanide (HCN) and cyanide salts (CN salts) |
male |
AB |
--- |
5-Jul-13 |
|
Cyanide salts that readily dissociate in solution (expressed as cyanide)f |
|
|
|
|
9.8 |
Hydrogen cyanidef |
|
|
|
|
10 (oral) |
Sodium cyanidef |
|
|
|
|
19 (oral) |
Potassium cyanidef |
|
|
|
|
25 (oral) |
1-Hydroxyanthraquinone |
cancer |
LC |
129-43-1 |
27-May-05 |
|
Hydroxyurea |
developmental |
FR |
127-07-1 |
1-May-97 |
|
Idarubicin hydrochloride |
developmental, male |
FR |
57852-57-0 |
20-Aug-99 |
|
Ifosfamide |
developmental |
FR |
3778-73-2 |
1-Jul-90 |
|
Iodine-131 |
developmental |
SQE |
10043-66-0 |
1-Jan-89 |
|
Imazalil |
cancer |
AB |
35554-44-0 |
20-May-11 |
11 |
Indeno [1,2,3-cd]pyrene |
cancer |
SQE |
193-39-5 |
1-Jan-88 |
|
Indium phosphide |
cancer |
AB |
22398-80-7 |
27-Feb-01 |
|
IQ (2-Amino-3-methylimidazo[4,5-f] quinoline) |
cancer |
AB |
76180-96-6 |
1-Apr-90 |
0.5 |
Iprodione |
cancer |
AB |
36734-19-7 |
1-May-96 |
|
Iprovalicarb |
cancer |
AB |
140923-17-7/
140923-25-7 |
1-Jun-07 |
|
Iron dextran complex |
cancer |
SQE |
9004-66-4 |
1-Jan-88 |
|
Isobutyl nitrite |
cancer |
AB |
542-56-3 |
1-May-96 |
7.4 |
Isoprene |
cancer |
AB |
78-79-5 |
1-May-96 |
|
Isopyrazam |
cancer |
AB |
881685-58-1 |
24-Jul-12 |
|
Isosafrole [Delisted December 8, 2006] |
|
|
|
|
|
Isotretinoin |
developmental |
SQE |
4759-48-2 |
1-Jul-87 |
|
Isoxaflutole |
cancer |
AB |
141112-29-0 |
22-Dec-00 |
|
Kresoxim-methyl |
cancer |
AB |
143390-89-0 |
3-Feb-12 |
|
Lactofen |
cancer |
SQE |
77501-63-4 |
1-Jan-89 |
|
Lasiocarpine |
cancer |
SQE |
303-34-4 |
1-Apr-88 |
0.09 |
Lead [Basis for listing changed effective November 22, 2013] |
developmental, female, male |
FR |
--- |
27-Feb-87 |
0.5 |
Lead and lead compounds |
cancer |
AB |
--- |
1-Oct-92 |
|
Lead |
|
|
|
|
15 (oral) |
Lead acetate |
cancer |
SQE |
301-04-2 |
1-Jan-88 |
23 (oral) |
Lead phosphate |
cancer |
SQE |
7446-27-7 |
1-Apr-88 |
58 (oral) |
Lead subacetate |
cancer |
LC |
1335-32-6 |
1-Oct-89 |
41 (oral) |
Leather dust |
cancer |
LC |
--- |
29-Apr-11 |
|
Leuprolide acetate |
developmental, female, male |
FR |
74381-53-6 |
26-Aug-97 |
|
Levodopa |
developmental |
FR |
59-92-7 |
29-Jan-99 |
|
Levonorgestrel implants |
female |
FR |
797-63-7 |
15-May-98 |
|
Lindane and other hexachlorocyclohexane isomers |
cancer |
LC |
--- |
1-Oct-89 |
|
Linuron |
developmental |
AB |
330-55-2 |
19-Mar-99 |
460 |
Lithium carbonate |
developmental |
FR |
554-13-2 |
1-Jan-91 |
|
Lithium citrate |
developmental |
FR |
919-16-4 |
1-Jan-91 |
|
Lorazepam |
developmental |
FR |
846-49-1 |
1-Jul-90 |
|
Lovastatin |
developmental |
FR |
75330-75-5 |
1-Oct-92 |
|
Lynestrenol |
cancer |
AB |
52-76-6 |
27-Feb-01 |
|
Malonaldehyde, sodium salt |
cancer |
AB |
24382-04-5 |
29-Apr-11 |
|
Mancozeb |
cancer |
AB |
8018-01-7 |
1-Jan-90 |
|
Maneb |
cancer |
AB |
12427-38-2 |
1-Jan-90 |
|
Marijuana smoke |
cancer |
SQE |
--- |
19-Jun-09 |
|
Me-A-alpha-C (2-Amino-3-methyl-9H- pyrido[2,3-b]indole) |
cancer |
AB |
68006-83-7 |
1-Jan-90 |
0.6 |
Mebendazole |
developmental |
FR |
31431-39-7 |
20-Aug-99 |
|
Medroxyprogesterone acetate |
cancer |
AB |
71-58-9 |
1-Jan-90 |
|
Medroxyprogesterone acetate |
developmental |
FR |
71-58-9 |
1-Apr-90 |
|
Megestrol acetate |
cancer |
FR |
595-33-5 |
28-Mar-14 |
|
Megestrol acetate |
developmental |
FR |
595-33-5 |
1-Jan-91 |
|
MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) |
cancer |
AB |
77094-11-2 |
1-Oct-94 |
0.46 |
MeIQx (2-Amino-3,8- dimethylimidazo[4,5-f]quinoxaline) |
cancer |
AB |
77500-04-0 |
1-Oct-94 |
0.41 |
Melphalan |
cancer |
LC |
148-82-3 |
27-Feb-87 |
0.005 |
Melphalan |
developmental |
FR |
148-82-3 |
1-Jul-90 |
|
Menotropins |
developmental |
FR |
9002-68-0 |
1-Apr-90 |
|
Mepanipyrim |
cancer |
AB |
110235-47-7 |
1-Jul-08 |
|
Meprobamate |
developmental |
FR |
57-53-4 |
1-Jan-92 |
|
Mercaptopurine |
developmental |
FR |
6112-76-1 |
1-Jul-90 |
|
Mercury and mercury compounds |
developmental |
AB |
--- |
1-Jul-90 |
|
Merphalan |
cancer |
SQE |
531-76-0 |
1-Apr-88 |
|
Mestranol |
cancer |
SQE |
72-33-3 |
1-Apr-88 |
|
Metam potassium |
cancer |
AB |
137-41-7 |
31-Dec-10 |
|
Methacycline hydrochloride |
developmental |
FR |
3963-95-9 |
1-Jan-91 |
|
Metham sodium |
cancer |
AB |
137-42-8 |
6-Nov-98 |
|
Metham sodium |
developmental |
AB |
137-42-8 |
15-May-98 |
|
Methanol |
developmental |
AB |
67-56-1 |
16-Mar-12 |
47,000
(inhalation)
23,000
(oral) |
Methazole |
developmental |
AB |
20354-26-1 |
1-Dec-99 |
|
Methimazole |
developmental |
FR |
60-56-0 |
1-Jul-90 |
|
Methotrexate |
developmental |
SQE |
59-05-2 |
1-Jan-89 |
|
Methotrexate sodium |
developmental |
FR |
15475-56-6 |
1-Apr-90 |
|
5-Methoxypsoralen with ultraviolet A therapy |
cancer |
SQE |
484-20-8 |
1-Oct-88 |
|
8-Methoxypsoralen with ultraviolet A therapy |
cancer |
LC |
298-81-7 |
27-Feb-87 |
|
2-Methylaziridine (Propyleneimine) |
cancer |
SQE |
75-55-8 |
1-Jan-88 |
0.028 |
Methylazoxymethanol |
cancer |
SQE |
590-96-5 |
1-Apr-88 |
|
Methylazoxymethanol acetate |
cancer |
SQE |
592-62-1 |
1-Apr-88 |
|
Methyl bromide, as a structural fumigant |
developmental |
FR |
74-83-9 |
1-Jan-93 |
810
(inhalation) |
Methyl n-butyl ketone |
male |
LC |
591-78-6 |
7-Aug-09 |
|
Methyl carbamate |
cancer |
AB |
598-55-0 |
15-May-98 |
160 |
Methyl chloride |
developmental |
AB |
74-87-3 |
10-Mar-00 |
|
Methyl chloride [Basis for listing changed effective March 7, 2014] |
male |
AB |
74-87-3 |
7-Aug-09 |
|
3-Methylcholanthrene |
cancer |
AB |
56-49-5 |
1-Jan-90 |
0.03 |
5-Methylchrysene |
cancer |
SQE |
3697-24-3 |
1-Apr-88 |
0.0084
(oral) |
4,4'-Methylene bis(2-chloroaniline) |
cancer |
FR |
101-14-4 |
1-Jul-87 |
0.5 |
4,4'-Methylene bis(N,N- dimethyl)benzenamine |
cancer |
LC |
101-61-1 |
1-Oct-89 |
20 |
4,4'-Methylene bis(2-methylaniline) |
cancer |
SQE |
838-88-0 |
1-Apr-88 |
0.8 |
4,4'-Methylenedianiline |
cancer |
SQE |
101-77-9 |
1-Jan-88 |
0.4 |
4,4'-Methylenedianiline dihydrochloride |
cancer |
SQE |
13552-44-8 |
1-Jan-88 |
0.6 |
Methyleugenol |
cancer |
AB |
93-15-2 |
16-Nov-01 |
|
Methylhydrazine and its salts |
cancer |
AB |
--- |
1-Jul-92 |
|
Methylhydrazine |
|
|
|
|
0.058 (oral)
0.090
(inhalation) |
Methylhydrazine sulfate |
|
|
|
|
0.18 |
2-Methylimidazole |
cancer |
LC |
693-98-1 |
22-Jun-12 |
|
4-Methylimidazole |
cancer |
AB |
822-36-6 |
7-Jan-11 |
29 |
Methyl iodide |
cancer |
SQE |
74-88-4 |
1-Apr-88 |
|
Methyl isobutyl ketone |
cancer |
LC |
108-10-1 |
4-Nov-11 |
|
Methyl isobutyl ketone (MIBK) |
developmental |
AB |
108-10-1 |
28-Mar-14 |
|
Methyl isocyanate (MIC) |
developmental, female |
SQE |
624-83-9 |
12-Nov-10 |
|
Methyl isopropyl ketone [Delisted April 4, 2014] |
|
|
|
|
|
Methyl mercury |
developmental |
SQE |
--- |
1-Jul-87 |
|
Methylmercury compounds |
cancer |
AB |
--- |
1-May-96 |
|
Methyl methanesulfonate |
cancer |
SQE |
66-27-3 |
1-Apr-88 |
7 |
2-Methyl-1-nitroanthraquinone (of uncertain purity) |
cancer |
SQE |
129-15-7 |
1-Apr-88 |
0.2 |
N-Methyl-N'-nitro-N-nitrosoguanidine |
cancer |
SQE |
70-25-7 |
1-Apr-88 |
0.08 |
N-Methylolacrylamide |
cancer |
AB |
924-42-5 |
1-Jul-90 |
|
N-Methylpyrrolidone |
developmental |
AB |
872-50-4 |
15-Jun-01 |
3200 (inhalation) 17000 (dermal) |
a-Methyl styrene (alpha-Methylstyrene) |
cancer |
LC |
98-83-9 |
2-Nov-12 |
|
a-Methyl styrene [Delisted April 4, 2014] |
|
|
|
|
|
Methyltestosterone |
developmental |
FR |
58-18-4 |
1-Apr-90 |
|
Methylthiouracil |
cancer |
LC |
56-04-2 |
1-Oct-89 |
2 |
Metiram |
cancer |
AB |
9006-42-2 |
1-Jan-90 |
|
Metiram |
developmental |
AB |
9006-42-2 |
30-Mar-99 |
|
Metronidazole |
cancer |
SQE |
443-48-1 |
1-Jan-88 |
|
Michler's ketone |
cancer |
SQE |
90-94-8 |
1-Jan-88 |
0.8 |
Midazolam hydrochloride |
developmental |
FR |
59467-96-8 |
1-Jul-90 |
|
Minocycline hydrochloride (internal use) |
developmental |
FR |
13614-98-7 |
1-Jan-92 |
|
Mirex |
cancer |
SQE |
2385-85-5 |
1-Jan-88 |
0.04 |
Misoprostol |
developmental |
FR |
59122-46-2 |
1-Apr-90 |
|
Mitomycin C |
cancer |
SQE |
50-07-7 |
1-Apr-88 |
0.00009 |
Mitoxantrone hydrochloride |
developmental |
FR |
70476-82-3 |
1-Jul-90 |
|
Molinate |
developmental, female, male |
AB |
2212-67-1 |
11-Dec-09 |
|
MON 4660 (dichloroacetyl-1-oxa-4- azaspiro(4,5)-decane |
cancer |
AB |
71526-07-3 |
22-Mar-11 |
|
MON 13900 (furilazole) |
cancer |
AB |
121776-33-8 |
22-Mar-11 |
|
3-Monochloropropane-1,2-diol (3- MCDP) |
cancer |
SQE |
96-24-2 |
8-Oct-10 |
|
Monocrotaline |
cancer |
SQE |
315-22-0 |
1-Apr-88 |
0.07 |
MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) |
cancer |
LC |
113803-47-7 |
4-Nov-11 |
|
5-(Morpholinomethyl)-3-[(5- nitrofurfurylidene)-mino]-2- oxazolidinone |
cancer |
SQE |
139-91-3 |
1-Apr-88 |
0.18 |
Mustard Gas |
cancer |
LC |
505-60-2 |
27-Feb-87 |
|
MX (3-chloro-4-dichloromethyl-5- hydroxy-2(5H)-furanone) |
cancer |
SQE |
77439-76-0 |
22-Dec-00 |
0.11 |
Myclobutanil |
developmental, male |
AB |
88671-89-0 |
16-Apr-99 |
|
Nabam |
developmental |
AB |
142-59-6 |
30-Mar-99 |
|
Nafarelin acetate |
developmental |
FR |
86220-42-0 |
1-Apr-90 |
|
Nafenopin |
cancer |
SQE |
3771-19-5 |
1-Apr-88 |
|
Nalidixic acid |
cancer |
AB |
389-08-2 |
15-May-98 |
28 |
Naphthalene |
cancer |
AB |
91-20-3 |
19-Apr-02 |
5.8 |
1-Naphthylamine |
cancer |
LC |
134-32-7 |
1-Oct-89 |
|
2-Naphthylamine |
cancer |
LC |
91-59-8 |
27-Feb-87 |
0.4 |
Neomycin sulfate (internal use) |
developmental |
FR |
1405-10-3 |
1-Oct-92 |
|
Netilmicin sulfate |
developmental |
FR |
56391-57-2 |
1-Jul-90 |
|
Nickel (Metallic) |
cancer |
LC |
7440-02-0 |
1-Oct-89 |
|
Nickel acetate |
cancer |
LC |
373-02-4 |
1-Oct-89 |
|
Nickel carbonate |
cancer |
LC |
3333-67-3 |
1-Oct-89 |
|
Nickel carbonyl |
cancer |
SQE |
13463-39-3 |
1-Oct-87 |
|
Nickel carbonyl |
developmental |
AB |
13463-39-3 |
1-Sep-96 |
|
Nickel compounds |
cancer |
LC |
--- |
7-May-04 |
|
Nickel hydroxide |
cancer |
LC |
12054-48-7;
12125-56-3 |
1-Oct-89 |
|
Nickelocene |
cancer |
LC |
1271-28-9 |
1-Oct-89 |
|
Nickel oxide |
cancer |
LC |
1313-99-1 |
1-Oct-89 |
|
Nickel refinery dust from the pyrometallurgical process |
cancer |
SQE |
--- |
1-Oct-87 |
0.8 |
Nickel subsulfide |
cancer |
SQE |
12035-72-2 |
1-Oct-87 |
0.4 |
Nicotine |
developmental |
FR |
54-11-5 |
1-Apr-90 |
|
Nifedipine |
developmental, female, male |
FR |
21829-25-4 |
29-Jan-99 |
|
Nimodipine |
developmental |
FR |
66085-59-4 |
24-Apr-01 |
|
Niridazole |
cancer |
SQE |
61-57-4 |
1-Apr-88 |
|
Nitrapyrin |
cancer |
AB |
1929-82-4 |
5-Oct-05 |
|
Nitrapyrin |
developmental |
AB |
1929-82-4 |
30-Mar-99 |
|
Nitrilotriacetic acid |
cancer |
SQE |
139-13-9 |
1-Jan-88 |
100 |
Nitrilotriacetic acid, trisodium salt monohydrate |
cancer |
SQE |
18662-53-8 |
1-Apr-89 |
70 |
5-Nitroacenaphthene |
cancer |
SQE |
602-87-9 |
1-Apr-88 |
6 |
5-Nitro-o-anisidine [Delisted December 8, 2006] |
|
|
|
|
|
o-Nitroanisole |
cancer |
AB |
91-23-6 |
1-Oct-92 |
|
Nitrobenzene |
cancer |
AB |
98-95-3 |
26-Aug-97 |
|
Nitrobenzene |
male |
AB |
98-95-3 |
30-Mar-10 |
|
4-Nitrobiphenyl |
cancer |
SQE |
92-93-3 |
1-Apr-88 |
|
6-Nitrochrysene |
cancer |
AB |
7496-02-8 |
1-Oct-90 |
|
Nitrofen (technical grade) |
cancer |
SQE |
1836-75-5 |
1-Jan-88 |
9 |
2-Nitrofluorene |
cancer |
AB |
607-57-8 |
1-Oct-90 |
|
Nitrofurantoin |
male |
AB |
67-20-9 |
1-Apr-91 |
|
Nitrofurazone |
cancer |
AB |
59-87-0 |
1-Jan-90 |
0.5 |
1-[(5-Nitrofurfurylidene)-amino]-2- imidazolidinone |
cancer |
SQE |
555-84-0 |
1-Apr-88 |
0.4 |
N-[4-(5-Nitro-2-furyl)-2- thiazolyl]acetamide |
cancer |
SQE |
531-82-8 |
1-Apr-88 |
0.5 |
Nitrogen mustard (Mechlorethamine) |
cancer |
SQE |
51-75-2 |
1-Jan-88 |
|
Nitrogen mustard (Mechlorethamine) |
developmental |
SQE |
51-75-2 |
1-Jan-89 |
|
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) |
cancer |
SQE |
55-86-7 |
1-Apr-88 |
|
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) |
developmental |
FR |
55-86-7 |
1-Jul-90 |
|
Nitrogen mustard N-oxide |
cancer |
SQE |
126-85-2 |
1-Apr-88 |
|
Nitrogen mustard N-oxide hydrochloride |
cancer |
SQE |
302-70-5 |
1-Apr-88 |
|
Nitromethane |
cancer |
AB |
75-52-5 |
1-May-97 |
39 |
2-Nitropropane |
cancer |
SQE |
79-46-9 |
1-Jan-88 |
|
1-Nitropyrene |
cancer |
AB |
5522-43-0 |
1-Oct-90 |
|
4-Nitropyrene |
cancer |
AB |
57835-92-4 |
1-Oct-90 |
|
N-Nitrosodiethanolamine |
cancer |
SQE |
1116-54-7 |
1-Jan-88 |
0.3 |
N-Nitrosodiethylamine |
cancer |
SQE |
55-18-5 |
1-Oct-87 |
0.02 |
N-Nitrosodimethylamine |
cancer |
SQE |
62-75-9 |
1-Oct-87 |
0.04 |
N-Nitrosodi-n-butylamine |
cancer |
SQE |
924-16-3 |
1-Oct-87 |
0.06 |
N-Nitrosodi-n-propylamine |
cancer |
SQE |
621-64-7 |
1-Jan-88 |
0.1 |
p-Nitrosodiphenylamine |
cancer |
SQE |
156-10-5 |
1-Jan-88 |
30 |
N-Nitrosodiphenylamine |
cancer |
SQE |
86-30-6 |
1-Apr-88 |
80 |
3-(N-Nitrosomethylamino) propionitrile |
cancer |
AB |
60153-49-3 |
1-Apr-90 |
|
4-(N-Nitrosomethylamino)-1-(3- pyridyl)1-butanone |
cancer |
AB |
64091-91-4 |
1-Apr-90 |
0.014 |
N-Nitrosomethylethylamine |
cancer |
LC |
10595-95-6 |
1-Oct-89 |
0.03 |
N-Nitrosomethylvinylamine |
cancer |
SQE |
4549-40-0 |
1-Jan-88 |
|
N-Nitrosomorpholine |
cancer |
SQE |
59-89-2 |
1-Jan-88 |
0.1 |
N-Nitroso-N-ethylurea |
cancer |
SQE |
759-73-9 |
1-Oct-87 |
0.03 |
N-Nitroso-N-methylurea |
cancer |
SQE |
684-93-5 |
1-Oct-87 |
0.006 |
N-Nitroso-N-methylurethane |
cancer |
SQE |
615-53-2 |
1-Apr-88 |
0.006 |
N-Nitrosonornicotine |
cancer |
SQE |
16543-55-8 |
1-Jan-88 |
0.5 |
N-Nitrosopiperidine |
cancer |
SQE |
100-75-4 |
1-Jan-88 |
0.07 |
N-Nitrosopyrrolidine |
cancer |
SQE |
930-55-2 |
1-Oct-87 |
0.3 |
N-Nitrososarcosine |
cancer |
SQE |
13256-22-9 |
1-Jan-88 |
|
o-Nitrotoluene |
cancer |
AB |
88-72-2 |
15-May-98 |
|
Nitrous oxide [Basis for listing changed effective November 8, 2013] |
developmental, female |
AB |
10024-97-2 |
1-Aug-08 |
|
Norethisterone (Norethindrone) |
cancer |
LC |
68-22-4 |
1-Oct-89 |
|
Norethisterone (Norethindrone) |
developmental |
FR |
68-22-4 |
1-Apr-90 |
|
Norethisterone acetate (Norethindrone acetate) |
developmental |
FR |
51-98-9 |
1-Oct-91 |
|
Norethisterone (Norethindrone) /Ethinyl estradiol |
developmental |
FR |
568-22-4/
7-63-6 |
1-Apr-90 |
|
Norethisterone (Norethindrone) /Mestranol |
developmental |
FR |
68-22-4/
72-33-3 |
1-Apr-90 |
|
Norethynodrel |
cancer |
AB |
68-23-5 |
27-Feb-01 |
|
Norgestrel |
developmental |
FR |
6533-00-2 |
1-Apr-90 |
|
Ochratoxin A |
cancer |
AB |
303-47-9 |
1-Jul-90 |
|
Oil Orange SS |
cancer |
SQE |
2646-17-5 |
1-Apr-88 |
|
Oral contraceptives, combined |
cancer |
LC |
--- |
1-Oct-89 |
|
Oral contraceptives, sequential |
cancer |
LC |
--- |
1-Oct-89 |
|
Oryzalin |
cancer |
AB |
19044-88-3 |
12-Sep-08 |
|
Oxadiazon |
cancer |
SQE |
19666-30-9 |
1-Jul-91 |
|
Oxadiazon |
developmental |
AB |
19666-30-9 |
15-May-98 |
|
Oxazepam |
cancer |
AB |
604-75-1 |
1-Oct-94 |
|
Oxazepam |
developmental |
FR |
604-75-1 |
1-Oct-92 |
|
p,p'-Oxybis(benzenesulfonyl hydrazide) [Delisted December 13, 2013] |
|
|
|
|
|
Oxydemeton methyl |
female, male |
AB |
301-12-2 |
6-Nov-98 |
|
Oxymetholone |
cancer |
SQE |
434-07-1 |
1-Jan-88 |
|
Oxymetholone |
developmental |
FR |
434-07-1 |
1-May-97 |
|
Oxytetracycline (internal use) |
developmental |
FR |
79-57-2 |
1-Jan-91 |
|
Oxytetracycline hydrochloride (internal use) |
developmental |
FR |
2058-46-0 |
1-Oct-91 |
|
Oxythioquinox (Chinomethionat) |
cancer |
AB |
2439-01-2 |
20-Aug-99 |
|
Oxythioquinox (Chinomethionat) |
developmental |
AB |
2439-01-2 |
6-Nov-98 |
|
Paclitaxel |
developmental, female, male |
FR |
33069-62-4 |
26-Aug-97 |
|
Palygorskite fibers (> 5mm in length) |
cancer |
AB |
12174-11-7 |
28-Dec-99 |
|
Panfuran S |
cancer |
SQE |
794-93-4 |
1-Jan-88 |
|
Paramethadione |
developmental |
FR |
115-67-3 |
1-Jul-90 |
|
Penicillamine |
developmental |
FR |
52-67-5 |
1-Jan-91 |
|
Pentachlorophenol |
cancer |
AB |
87-86-5 |
1-Jan-90 |
40 |
Pentobarbital sodium |
developmental |
FR |
57-33-0 |
1-Jul-90 |
|
Pentosan polysulfate sodium |
cancer |
LC |
--- |
18-Apr-14 |
|
Pentostatin |
developmental |
FR |
53910-25-1 |
1-Sep-96 |
|
Phenacemide |
developmental |
FR |
63-98-9 |
1-Jul-90 |
|
Phenacetin |
cancer |
LC |
62-44-2 |
1-Oct-89 |
300 |
Phenazopyridine |
cancer |
SQE |
94-78-0 |
1-Jan-88 |
4 |
Phenazopyridine hydrochloride |
cancer |
SQE |
136-40-3 |
1-Jan-88 |
5 |
Phenesterin |
cancer |
SQE |
3546-10-9 |
1-Jul-89 |
0.005 |
Phenobarbital |
cancer |
AB |
50-06-6 |
1-Jan-90 |
2 |
Phenolphthalein |
cancer |
AB |
77-09-8 |
15-May-98 |
|
Phenoxybenzamine |
cancer |
SQE |
59-96-1 |
1-Apr-88 |
0.2 |
Phenoxybenzamine hydrochloride |
cancer |
SQE |
63-92-3 |
1-Apr-88 |
0.3 |
Phenprocoumon |
developmental |
FR |
435-97-2 |
1-Oct-92 |
|
o-Phenylenediamine and its salts |
cancer |
AB |
95-54-5 |
15-May-98 |
|
o-Phenylenediamine |
|
|
|
|
26 |
o-Phenylenediamine dihydochloride |
|
|
|
|
44 |
Phenyl glycidyl ether |
cancer |
AB |
122-60-1 |
1-Oct-90 |
5 |
Phenyl glycidyl ether [Delisted April 4, 2014] |
|
LC |
|
|
|
Phenylhydrazine and its salts |
cancer |
AB |
--- |
1-Jul-92 |
|
Phenylhydrazine |
|
|
|
|
1 |
Phenylhydrazine hydrochloride |
|
|
|
|
1.4 |
o-Phenylphenate, sodium |
cancer |
AB |
132-27-4 |
1-Jan-90 |
200 |
o-Phenylphenol |
cancer |
AB |
90-43-7 |
4-Aug-00 |
|
Phenylphosphine [Basis for listing changed effective June 6, 2014] |
developmental male |
LC SQE |
638-21-1 |
7-Aug-09 |
|
PhiP(2-Amino-1-methyl-6- phenylimidazol[4,5-b]pyridine) |
cancer |
AB |
105650-23-5 |
1-Oct-94 |
|
Pimozide |
developmental, female |
FR |
2062-78-4 |
20-Aug-99 |
|
Pioglitazone |
cancer |
LC |
111025-46-8 |
18-Apr-14 |
|
Pipobroman |
developmental |
FR |
54-91-1 |
1-Jul-90 |
|
Pirimicarb |
cancer |
AB |
23103-98-2 |
1-Jul-08 |
|
Plicamycin |
developmental |
FR |
18378-89-7 |
1-Apr-90 |
|
Polybrominated biphenyls |
cancer |
SQE |
--- |
1-Jan-88 |
0.02 |
Polybrominated biphenyls |
developmental |
AB |
--- |
1-Oct-94 |
|
Polychlorinated biphenyls |
cancer |
LC |
--- |
1-Oct-89 |
0.09 |
Polychlorinated biphenyls |
developmental |
SQE |
--- |
1-Jan-91 |
|
Polychlorinated biphenyls (containing 60 or more percent percent chlorine by molecular weight) |
cancer |
SQE |
--- |
1-Jan-88 |
|
Polychlorinated dibenzo-p-dioxins |
cancer |
FR |
--- |
1-Oct-92 |
|
Polychlorinated dibenzofurans |
cancer |
FR |
--- |
1-Oct-92 |
|
Polygeenan |
cancer |
SQE |
53973-98-1 |
1-Jan-88 |
1200 |
Ponceau MX |
cancer |
SQE |
3761-53-3 |
1-Apr-88 |
200 |
Ponceau 3R |
cancer |
SQE |
3564-09-8 |
1-Apr-88 |
40 |
Potassium bromate |
cancer |
AB |
7758-01-2 |
1-Jan-90 |
1 |
Potassium dimethyldithiocarbamate |
developmental |
AB |
128-03-0 |
30-Mar-99 |
720 |
Pravastatin sodium |
developmental |
FR |
81131-70-6 |
3-Mar-00 |
|
Prednisolone sodium phosphate |
developmental |
FR |
125-02-0 |
20-Aug-99 |
|
Primidone |
cancer |
AB |
125-33-7 |
20-Aug-99 |
|
Procarbazine |
cancer |
SQE |
671-16-9 |
1-Jan-88 |
0.05 |
Procarbazine hydrochloride |
cancer |
SQE |
366-70-1 |
1-Jan-88 |
0.06 |
Procarbazine hydrochloride |
developmental |
FR |
366-70-1 |
1-Jul-90 |
|
Procymidone |
cancer |
AB |
32809-16-8 |
1-Oct-94 |
|
Progesterone |
cancer |
SQE |
57-83-0 |
1-Jan-88 |
|
Pronamide |
cancer |
AB |
23950-58-5 |
1-May-96 |
|
Propachlor |
cancer |
AB |
1918-16-7 |
27-Feb-01 |
|
1,3-Propane sultone |
cancer |
SQE |
1120-71-4 |
1-Jan-88 |
0.3 |
Propargite |
cancer |
AB |
2312-35-8 |
1-Oct-94 |
|
Propargite |
developmental |
AB |
2312-35-8 |
15-Jun-99 |
|
beta-Propiolactone |
cancer |
SQE |
57-57-8 |
1-Jan-88 |
0.05 |
Propoxur |
cancer |
AB |
114-26-1 |
11-Aug-06 |
|
Propylene glycol mono-t-butyl ether |
cancer |
AB |
57018-52-7 |
11-Jun-04 |
|
Propylene oxide |
cancer |
SQE |
75-56-9 |
1-Oct-88 |
|
Propylthiouracil |
cancer |
SQE |
51-52-5 |
1-Jan-88 |
0.7 |
Propylthiouracil |
developmental |
FR |
51-52-5 |
1-Jul-90 |
|
Pulegone |
cancer |
LC |
89-82-7 |
18-Apr-14 |
|
Pymetrozine |
cancer |
AB |
123312-89-0 |
22-Mar-11 |
|
Pyridine |
cancer |
AB |
110-86-1 |
17-May-02 |
|
Pyrimethamine |
developmental |
FR |
58-14-0 |
29-Jan-99 |
|
Quazepam |
developmental |
FR |
36735-22-5 |
26-Aug-97 |
|
Quinoline and its strong acid salts |
cancer |
SQE |
--- |
24-Oct-97 |
|
Quizalofop-ethyl |
male |
SQE |
76578-14-8 |
24-Dec-99 |
590 |
Radionuclides |
cancer |
SQE |
--- |
1-Jul-89 |
|
Reserpine |
cancer |
LC |
50-55-5 |
1-Oct-89 |
0.06 |
Residual (heavy) fuel oils |
cancer |
AB |
--- |
1-Oct-90 |
|
Resmethrin |
cancer |
AB |
10453-86-8 |
1-Jul-08 |
|
Resmethrin |
developmental |
AB |
10453-86-8 |
6-Nov-98 |
|
Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) |
developmental |
SQE |
--- |
1-Jul-89 |
|
Ribavirin |
developmental |
FR |
36791-04-5 |
1-Apr-90 |
|
Ribavirin |
male |
FR |
36791-04-5 |
27-Feb-01 |
|
Riddelliine |
cancer |
LC |
23246-96-0 |
3-Dec-04 |
|
Rifampin |
developmental, female |
FR |
13292-46-1 |
27-Feb-01 |
|
Saccharin [Delisted April 6, 2001] |
|
|
|
|
|
Saccharin, sodium [Delisted January 17, 2003] |
|
|
|
|
|
Safrole |
cancer |
SQE |
94-59-7 |
1-Jan-88 |
3 |
Salted fish, Chinese-style |
cancer |
LC |
--- |
29-Apr-11 |
|
Secobarbital sodium |
developmental |
FR |
309-43-3 |
1-Oct-92 |
|
Selenium sulfide |
cancer |
LC |
7446-34-6 |
1-Oct-89 |
|
Sermorelin acetate |
developmental |
FR |
--- |
20-Aug-99 |
|
Shale-oils |
cancer |
AB |
68308-34-9 |
1-Apr-90 |
|
Silica, crystalline (airborne particles of respirable size) |
cancer |
SQE |
--- |
1-Oct-88 |
|
Sodium dimethyldithiocarbamate |
developmental |
AB |
128-04-1 |
30-Mar-99 |
23 (oral)
58 (oral) as
a 40%
pesticidal formulation |
Sodium fluoroacetate |
male |
AB |
62-74-8 |
6-Nov-98 |
|
Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) |
cancer |
LC |
--- |
27-Feb-87 |
|
Spirodiclofen |
cancer |
AB |
148477-71-8 |
8-Oct-10 |
|
Spironolactone |
cancer |
FR |
52-01-7 |
1-May-97 |
|
Stanozolol |
cancer |
FR |
10418-03-8 |
1-May-97 |
|
Sterigmatocystin |
cancer |
SQE |
10048-13-2 |
1-Apr-88 |
0.02 |
Streptomycin sulfate |
developmental |
|
3810-74-0 |
1-Jan-91 |
|
Streptozocin (streptozotocin) |
developmental, female, male |
FR |
18883-66-4 |
20-Aug-99 |
|
Streptozotocin (streptozocin) |
cancer |
SQE |
18883-66-4 |
1-Jan-88 |
0.006 |
Strong inorganic acid mists containing sulfuric acid |
cancer |
AB |
--- |
14-Mar-03 |
|
Styrene oxide |
cancer |
SQE |
96-09-3 |
1-Oct-88 |
4 |
Sulfallate |
cancer |
SQE |
95-06-7 |
1-Jan-88 |
4 |
Sulfasalazine (salicylazosulfapyridine) |
cancer |
AB |
599-79-1 |
15-May-98 |
|
Sulfasalazine (salicylazosulfapyridine) |
male |
FR |
599-79-1 |
29-Jan-99 |
|
Sulfur dioxidee |
developmental |
SQE |
7446-09-5 |
29-Jul-11 |
10000 |
Sulindac |
developmental, female |
FR |
38194-50-2 |
29-Jan-99 |
|
Talc containing asbestiform fibers |
cancer |
AB |
--- |
1-Apr-90 |
|
Tamoxifen and its salts |
cancer |
SQE |
10540-29-1 |
1-Sep-96 |
|
Tamoxifen citrate |
developmental |
FR |
54965-24-1 |
1-Jul-90 |
|
Temazepam |
developmental |
FR |
846-50-4 |
1-Apr-90 |
|
Teniposide |
developmental |
FR |
29767-20-2 |
1-Sep-96 |
|
Terbacil |
developmental |
AB |
5902-51-2 |
18-May-99 |
|
Terrazole |
cancer |
AB |
2593-15-9 |
1-Oct-94 |
|
Testosterone and its esters |
cancer |
SQE |
58-22-0 |
1-Apr-88 |
|
Testosterone cypionate |
developmental |
FR |
58-20-8 |
1-Oct-91 |
|
Testosterone enanthate |
developmental |
FR |
315-37-7 |
1-Apr-90 |
|
3,3',4,4'-Tetrachloroazobenzene |
cancer |
AB |
14047-09-7 |
24-Jul-12 |
|
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) |
cancer |
SQE |
1746-01-6 |
1-Jan-88 |
0.000005 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) |
developmental |
AB |
1746-01-6 |
1-Apr-91 |
|
1,1,1,2-Tetrachloroethane |
cancer |
LC |
630-20-6 |
13-Sep-13 |
|
1,1,2,2-Tetrachloroethane |
cancer |
AB |
79-34-5 |
1-Jul-90 |
3 |
Tetrachloroethylene (Perchloroethylene) |
cancer |
SQE |
127-18-4 |
1-Apr-88 |
14 |
p-a,a,a-Tetrachlorotoluene |
cancer |
AB |
5216-25-1 |
1-Jan-90 |
|
Tetracycline (internal use) |
developmental |
FR |
60-54-8 |
1-Oct-91 |
|
Tetracyclines (internal use) |
developmental |
FR |
--- |
1-Oct-92 |
|
Tetracycline hydrochloride (internal use) |
developmental |
FR |
64-75-5 |
1-Jan-91 |
|
Tetrafluoroethylene |
cancer |
AB |
116-14-3 |
1-May-97 |
|
Tetranitromethane |
cancer |
AB |
509-14-8 |
1-Jul-90 |
0.059 |
Thalidomide |
developmental |
SQE |
50-35-1 |
1-Jul-87 |
|
Thioacetamide |
cancer |
SQE |
62-55-5 |
1-Jan-88 |
0.1 |
4,4'-Thiodianiline |
cancer |
SQE |
139-65-1 |
1-Apr-88 |
0.05 |
Thiodicarb |
cancer |
AB |
59669-26-0 |
20-Aug-99 |
|
Thioguanine |
developmental |
FR |
154-42-7 |
1-Jul-90 |
|
Thiophanate methyl |
female, male |
AB |
23564-05-8 |
18-May-99 |
600 (oral) |
Thiouracil |
cancer |
AB |
141-90-2 |
11-Jun-04 |
|
Thiourea |
cancer |
SQE |
62-56-6 |
1-Jan-88 |
10 |
Thorium dioxide |
cancer |
LC |
1314-20-1 |
27-Feb-87 |
|
Titanium dioxide (airborne, unbound particles of respirable size) |
cancer |
LC |
--- |
2-Sep-11 |
|
Tobacco, oral use of smokeless products |
cancer |
SQE |
--- |
1-Apr-88 |
|
Tobacco smoke |
cancer |
SQE |
--- |
1-Apr-88 |
|
Tobacco smoke (primary) |
developmental, female, male |
SQE |
--- |
1-Apr-88 |
|
Tobramycin sulfate |
developmental |
FR |
49842-07-1 |
1-Jul-90 |
|
Toluene |
developmental |
SQE |
108-88-3 |
1-Jan-91 |
7000c |
Toluene [Basis for the removal of female reproductive endpoint effective March 7, 2014] |
|
|
|
|
|
Toluene diisocyanate |
cancer |
LC |
26471-62-5 |
1-Oct-89 |
20 |
o-Toluidine |
cancer |
SQE |
95-53-4 |
1-Jan-88 |
4 |
o-Toluidine hydrochloride |
cancer |
SQE |
636-21-5 |
1-Jan-88 |
5 |
para-Toluidine [Delisted October 29, 1999] |
|
|
|
|
|
Toxaphene (Polychlorinated camphenes) |
cancer |
SQE |
8001-35-2 |
1-Jan-88 |
0.6 |
Toxins derived from Fusarium moniliforme (Fusarium verticillioides) |
cancer |
LC |
--- |
7-Aug-09 |
|
Treosulfan |
cancer |
LC |
299-75-2 |
27-Feb-87 |
|
Triadimefon |
developmental, female, male |
AB |
43121-43-3 |
30-Mar-99 |
|
Triamterene |
cancer |
LC |
396-01-0 |
18-Apr-14 |
|
Triazolam |
developmental |
FR |
28911-01-5 |
1-Apr-90 |
|
S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF) |
cancer |
AB |
78-48-8 |
25-Feb-11 |
|
Tributyltin methacrylate |
developmental |
AB |
2155-70-6 |
1-Dec-99 |
|
Trichlormethine (Trimustine hydrochloride) |
cancer |
AB |
817-09-4 |
1-Jan-92 |
|
Trichloroacetic acid |
cancer |
LC |
76-03-9 |
13-Sep-13 |
|
Trichloroethylene |
cancer |
SQE |
79-01-6 |
1-Apr-88 |
14 (oral)
50
(inhalation) |
Trichloroethylene |
developmental, male |
AB |
79-01-6 |
31-Jan-14 |
|
2,4,6-Trichlorophenol |
cancer |
SQE |
88-06-2 |
1-Jan-88 |
10 |
1,2,3-Trichloropropane |
cancer |
AB |
96-18-4 |
1-Oct-92 |
|
Trientine hydrochloride |
developmental |
FR |
38260-01-4 |
27-Feb-01 |
|
Triforine |
developmental |
AB |
26644-46-2 |
18-Jun-99 |
|
1,3,5-Triglycidyl-s-triazinetrione [Delisted December 13, 2013] |
|
|
|
|
|
Trilostane |
developmental |
FR |
13647-35-3 |
1-Apr-90 |
|
Trimethadione |
developmental |
FR |
127-48-0 |
1-Jan-91 |
|
2,4,5-Trimethylaniline and its strong acid salts |
cancer |
SQE |
--- |
24-Oct-97 |
|
Trimethyl phosphate |
cancer |
AB |
512-56-1 |
1-May-96 |
24 |
Trimetrexate glucuronate |
developmental |
FR |
82952-64-5 |
26-Aug-97 |
|
2,4.6-Trinitrotoluene (TNT) |
cancer |
SQE |
118-96-7 |
19-Dec-08 |
8.2 |
Triphenyltin hydroxide |
cancer |
AB |
76-87-9 |
1-Jul-92 |
|
Triphenyltin hydroxide |
developmental |
AB |
76-87-9 |
18-Mar-02 |
|
Tris(aziridinyl)-p-benzoquinone (Triaziquone) [Delisted December 8, 2006] |
|
|
|
|
|
Tris(1-aziridinyl)phosphine sulfide (Thiotepa) |
cancer |
SQE |
52-24-4 |
1-Jan-88 |
0.06 |
Tris(2-chloroethyl) phosphate |
cancer |
AB |
115-96-8 |
1-Apr-92 |
|
Tris(2,3-dibromopropyl)phosphate |
cancer |
SQE |
126-72-7 |
1-Jan-88 |
0.3 |
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) |
cancer |
SQE |
13674-87-8 |
28-Oct-11 |
5.4 |
Trp-P-1 (Tryptophan-P-1) |
cancer |
SQE |
62450-06-0 |
1-Apr-88 |
0.03 |
Trp-P-2 (Tryptophan-P-2) |
cancer |
SQE |
62450-07-1 |
1-Apr-88 |
0.2 |
Trypan blue (commercial grade) |
cancer |
LC |
72-57-1 |
1-Oct-89 |
|
Unleaded gasoline (wholly vaporized) |
cancer |
SQE |
--- |
1-Apr-88 |
|
Uracil mustard |
cancer |
SQE |
66-75-1 |
1-Apr-88 |
|
Uracil mustard |
developmental, female, male |
FR |
66-75-1 |
1-Jan-92 |
|
Urethane (Ethyl carbamate) |
cancer |
SQE |
51-79-6 |
1-Jan-88 |
0.7 |
Urethane (Ethyl carbamate) |
developmental |
AB |
51-79-6 |
1-Oct-94 |
|
Urofollitropin |
developmental |
FR |
97048-13-0 |
1-Apr-90 |
|
Valproate (Valproic acid) |
developmental |
SQE |
99-66-1 |
1-Jul-87 |
|
Vanadium pentoxide (orthorhombic crystalline form) |
cancer |
AB |
1314-62-1 |
11-Feb-05 |
|
Vinblastine sulfate |
developmental |
FR |
143-67-9 |
1-Jul-90 |
|
Vinclozolin |
cancer |
AB |
50471-44-8 |
20-Aug-99 |
|
Vinclozolin |
developmental |
AB |
50471-44-8 |
15-May-98 |
|
Vincristine sulfate |
developmental |
FR |
2068-78-2 |
1-Jul-90 |
|
Vinyl bromide |
cancer |
SQE |
593-60-2 |
1-Oct-88 |
|
Vinyl chloride |
cancer |
LC |
75-01-4 |
27-Feb-87 |
3 |
4-Vinylcyclohexene |
cancer |
AB |
100-40-3 |
1-May-96 |
|
4-Vinylcyclohexene [Basis for the removal of male reproductive endpoint effective December 20, 2013] |
female |
SQE |
100-40--3 |
7-Aug-09 |
|
4-Vinyl-1-cyclohexene diepoxide (Vinyl cyclohexenedioxide) |
cancer |
AB |
106-87-6 |
1-Jul-90 |
|
Vinyl cyclohexene dioxide (4-Vinyl-1- cyclohexene diepoxide) [Basis for the removal of male reproductive endpoint effective December 20, 2013] |
female |
SQE |
106-87-6 |
1-Aug-08 |
|
Vinyl fluoride |
cancer |
AB |
75-02-5 |
1-May-97 |
|
Vinyl trichloride (1,1,2- Trichloroethane) |
cancer |
AB |
79-00-5 |
1-Oct-90 |
10 |
Warfarin |
developmental |
SQE |
81-81-2 |
1-Jul-87 |
|
Wood dust |
cancer |
LC |
--- |
18-Dec-09 |
|
|
|
|
|
|
|
2,6-Xylidine (2,6-Dimethylaniline) |
cancer |
AB |
87-62-7 |
1-Jan-91 |
110 |
|
|
|
|
|
|
Zalcitabine |
cancer |
LC |
7481-89-2 |
7-Aug-09 |
|
Zidovudine (AZT) |
cancer |
LC |
30516-87-1 |
18-Dec-09 |
|
Zileuton |
cancer, developmental, female |
FR |
111406-87-2 |
22-Dec-00 |
|
Zineb [Delisted October 29, 1999] |
|
|
|
|
|